Medtronic InFuse payment docked
This article was originally published in The Gray Sheet
Maximum add-on payment halved to $4,450 upon firm's notification that a single-level fusion requires only one product per procedure. CMS mistakenly believed two InFuse devices were needed, the agency explains in an 1Oct. 6 hospital inpatient prospective payment system correction notice. Medtronic is the first device firm to qualify for the new-tech provision (2"The Gray Sheet" Aug. 4, 2003, p. 6)...
You may also be interested in...
The device industry's hopes to reduce the Centers for Medicare & Medicaid Services' new technology "add-on" payment threshold are riding on a provision in the House's "Medicare Prescription Drug & Modernization Act" of 2003 (HR 1)
Policy experts predicted how the incoming Biden administration will handle health care issues at a recent Alliance for Health Policy webinar. Rachel Nuzum, VP of state and federal policy at The Commonwealth Fund, said telehealth could be a priority.
The China National Biotec Group has filed the first application in China for the broad use of a COVID-19 vaccine, days after the national regulatory agency released review guidelines for the conditional approval of such products.